TrialStem cell research & therapy2025

Mesenchymal stem cells combined with IFN-γ treatment versus mesenchymal stem cells monotherapy: safety and efficacy over five years extension follow-up.

Yi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.